Appointment of Joint Broker

RNS Number : 8247R
Frenkel Topping Group PLC
19 June 2018
 

Frenkel Topping Group plc

("Frenkel Topping" or "the Company")

Appointment of Joint Broker

Frenkel Topping (AIM: FEN), a specialist independent financial advisor and asset manager focused on asset protection for vulnerable clients, is pleased to announce the appointment of Whitman Howard Limited as its joint broker. finnCap remains Nominated Adviser and Joint Broker to the Company.

For further information:

Frenkel Topping Group plc

Paul Richardson, Executive Chairman

www.frenkeltopping.co.uk

Tel: 0161 886 8000



finnCap Ltd

Adrian Hargrave / James Thompson

Tim Redfern / Richard Chambers

Tel: 020 7220 0500



Whitman Howard Limited

Francis North (Corporate)

Araminta Lowes (Sales)

Tel: 020 7659 1234



Walbrook PR Ltd

Paul Cornelius / Nick Rome

Tel: 020 7933 8780 or

frenkeltopping@walbrookpr.com

 

About Frenkel Topping: www.frenkeltopping.co.uk

Frenkel Topping provides specialist independent financial advice focussed on asset protection for clients. The specialist independent financial adviser has a market leading position providing advice and fund management services for personal injury trusts and clinical negligence awards and is well placed to provide services to a wider customer base.

The Company provides a range of wealth management services including bespoke investment portfolios, financial and tax planning. It is focused on increasing its assets under management by growing the number of fee earners who are qualified to provide benefits protection for a variety of needs as the Company adds to its personal injury and clinical negligence specialism.

It has a national presence with offices in Manchester, Birmingham, Cardiff, London and Leeds and has relationships and infrastructure in place to further grow its reach and target markets.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPKMGMVVLNGRZG
Investor Meets Company
UK 100